Filing Details

Accession Number:
0001209191-10-017968
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-19 13:00:00
Reporting Period:
2010-03-17
Filing Date:
2010-03-19
Accepted Time:
2010-03-19 12:54:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1138400 Biomimetic Therapeutics Inc. BMTI Surgical & Medical Instruments & Apparatus (3841) 621786244
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1362155 Martin Earl Douglas Biomimetic Therapeutics, Inc.
389 Nichol Mill Lane
Franklin TN 37067
General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-17 18,000 $3.63 87,161 No 4 M Direct
Common Stock Acquisiton 2010-03-17 7,500 $3.63 94,661 No 4 M Direct
Common Stock Disposition 2010-03-17 6,975 $13.27 87,686 No 4 F Direct
Common Stock Disposition 2010-03-17 4,430 $13.30 83,256 No 4 S Direct
Common Stock Disposition 2010-03-17 570 $13.30 82,686 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2010-03-17 18,000 $0.00 18,000 $3.63
Common Stock Stock Options (right to buy) Disposition 2010-03-17 7,500 $0.00 7,500 $3.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2006-05-31 2010-05-31 No 4 M Direct
0 2007-01-01 2011-01-01 No 4 M Direct
Footnotes
  1. Includes 559 shares acquired by Mr. Douglas through the Biomimetic Therapeutics, Inc. 401(k) Plan matching funds (since the previous Form 4 filing).
  2. This transaction represents a withholding of shares to cover the payment of exercise price. In addition, the reporting person remitted $6.75 to finalize the transaction.
  3. Options vest 25% each year on the anniversary date of grant.